NZ Rheumatology Research Review Issue 52

In this issue:
  -  Aortic stenosis risk in RA
  -  TNF inhibitors, IL-6 inhibitors and methotrexate for ICI-associated arthritis
  -  Discontinuing long-term, low-dose glucocorticoids in elderly RA
  -  Methotrexate safety for men wanting to become a father
  -  2 years of low-dose glucocorticoids for RA: effects on weight and BP
  -  Rituximab vs. azathioprine for maintaining remission in ANCA-associated vasculitis
  -  Maintaining RA remission after change from combination to monotherapy
  -  MRI lesions at sacroiliac joint during and after pregnancy
  -  Flare after corticosteroids/ immunosuppressant tapering in SLE
  -  Natural sequence that subclinical joint inflammation subsides or progresses to RA
  -  Methotrexate, leflunomide and tacrolimus: progression of RA-associated ILD
  -  Stricter treat-to-target in RA does not lead to less radiographical progression

Please login below to download this issue (PDF)

Subscribe